$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 16, 2025)
$84.84M
Market Cap
-
P/E Ratio
-0.64
EPS
$3.16
52 Week High
$1.30
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Adagene Inc. is a clinical-stage biopharmaceutical company based in Suzhou, China, specializing in the development of innovative monoclonal antibody therapies for oncology. Utilizing its proprietary technologies, the company is at the forefront of creating next-generation antibody drug candidates designed to enhance therapeutic efficacy while minimizing adverse effects in cancer treatment. With a promising pipeline of drug candidates that address significant unmet medical needs within the oncology space, Adagene is poised to make impactful contributions to the biopharmaceutical industry and improve outcomes for patients battling cancer.
LPTX
VMAR
IVP
NVDA
CGC
PFE
TSLA
WOK
AAL
PLUG
ASST
WBD
IRBT
RZLV
F
AVGO
ADAP
INTC
PLTD
SNAP
TLRY
BYND
BITF
DFLI
IREN
SOFI
CIFR
RIG
PLTR
MARA
GRAB
CRBG
DNN
T
ALIT
HPE
APLD
NFLX
ORCL
PBR
WULF
BAC
GOOGL
CPNG
LAZR
VHAI
PCG
BTBT
RGTI
NIO
QBTS
VALE
RILY
AMC
KVUE
HBAN
NOK
UBER
AMD
CCL
CLSK
RKLB
MU
ITUB
GOOG
MSTR
HOOD
RR
SMR
MSFT
LPTX
VMAR
IVP
NVDA
CGC
PFE
TSLA
WOK
AAL
PLUG
ASST
WBD
IRBT
RZLV
F
AVGO
ADAP
INTC
PLTD
SNAP
TLRY
BYND
BITF
DFLI
IREN
SOFI
CIFR
RIG
PLTR
MARA
GRAB
CRBG
DNN
T
ALIT
HPE
APLD
NFLX
ORCL
PBR
WULF
BAC
GOOGL
CPNG
LAZR
VHAI
PCG
BTBT
RGTI
NIO
QBTS
VALE
RILY
AMC
KVUE
HBAN
NOK
UBER
AMD
CCL
CLSK
RKLB
MU
ITUB
GOOG
MSTR
HOOD
RR
SMR
MSFT